{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:55:08Z","timestamp":1792086908943,"version":"4.4.0"},"reference-count":73,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hodgkin lymphoma (HL) is characterized by inflammatory lesions with relatively few (typically &amp;lt;1%) pathogenic Hodgkin Reed-Sternberg (HRS) cells. The scarcity of malignant HRS cells in HL has historically limited characterization of these disease drivers, and pathogenic mechanisms underlying HL are incompletely defined. Using multiparameter flow cytometry to purify HRS cells and immune cell populations from pediatric HL lesions and control tonsils, we sought to define transcriptional programs in pediatric HRS cells. HRS cells are thought to arise from transformed germinal center B cells. Interestingly, transcriptomic analysis of HRS cells compared to control tonsil CD30+ cells revealed disordered differentiation with multilineage gene expression patterns, and primary HRS cells had distinct transcriptomes compared to HL cell lines. Further, transcriptomic analysis revealed increased expression of senescence-related genes and downregulation of proapoptotic\/mitosis-related genes. Gene expression findings were validated by immunohistochemistry and single-cell imaging. In vitro treatment of primary HRS cells with B-cell lymphoma 2 inhibitor, venetoclax, augmented the induction of apoptosis in HRS cells and other cells of the HL immune microenvironment. These findings support the further study of targeting apoptosis resistance as a potential approach to eliminate malignant HRS cells and dismantle inflammatory lesion formation in pediatric HL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016953","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T17:07:56Z","timestamp":1768496876000},"page":"2711-2726","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cells"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-863X","authenticated-orcid":false,"given":"Jennifer E.","family":"Agrusa","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"},{"name":"3Department of Pediatrics, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmoataz","family":"Abdel Fattah","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Lin","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4384-8744","authenticated-orcid":false,"given":"Jessica","family":"Velazquez","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-0467","authenticated-orcid":false,"given":"Sandra Andrea","family":"Salinas","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal A.","family":"Abhyankar","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooks P.","family":"Scull","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Fleischmann","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tarek","family":"Elghetany","sequence":"additional","affiliation":[{"name":"4Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX"},{"name":"5Department of Pathology, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea N.","family":"Marcogliese","sequence":"additional","affiliation":[{"name":"4Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX"},{"name":"5Department of Pathology, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choladda V.","family":"Curry","sequence":"additional","affiliation":[{"name":"4Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX"},{"name":"5Department of Pathology, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotinder N.","family":"Punia","sequence":"additional","affiliation":[{"name":"4Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX"},{"name":"5Department of Pathology, Texas Children's Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-7875","authenticated-orcid":false,"given":"Nmazuo W.","family":"Ozuah","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-8810","authenticated-orcid":false,"given":"Olive S.","family":"Eckstein","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-1046","authenticated-orcid":false,"given":"Nader K.","family":"El-Mallawany","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9243-9544","authenticated-orcid":false,"given":"Nitya","family":"Gulati","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lubega","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terzah M.","family":"Horton","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0892-7727","authenticated-orcid":false,"given":"Kala Y.","family":"Kamdar","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0725-6263","authenticated-orcid":false,"given":"Kenneth L.","family":"McClain","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz-Kwong","family":"Man","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Allen","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Baylor College of Medicine, Houston, TX"},{"name":"2Texas Children\u2019s Cancer and Hematology Center, Texas Children\u2019s Hospital, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"1","key":"2026042809471524600_bib1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pcl.2014.09.010","article-title":"Pediatric lymphomas and histiocytic disorders of childhood","volume":"62","author":"Allen","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"9","key":"2026042809471524600_bib2","doi-asserted-by":"crossref","first-page":"e0138416","DOI":"10.1371\/journal.pone.0138416","article-title":"Aberrantly expressed OTX homeobox genes deregulate B-cell differentiation in Hodgkin lymphoma","volume":"10","author":"Nagel","year":"2015","journal-title":"PLoS One"},{"issue":"17","key":"2026042809471524600_bib3","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","article-title":"Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma","volume":"120","author":"Steidl","year":"2012","journal-title":"Blood"},{"issue":"22","key":"2026042809471524600_bib4","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2017-11-814913","article-title":"Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma","volume":"131","author":"Tiacci","year":"2018","journal-title":"Blood"},{"issue":"6","key":"2026042809471524600_bib5","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"issue":"32","key":"2026042809471524600_bib6","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol"},{"issue":"15","key":"2026042809471524600_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"2026042809471524600_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1100340","article-title":"ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned","volume":"365","author":"Viviani","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2026042809471524600_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2010.08455.x","article-title":"Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents","volume":"152","author":"Daw","year":"2011","journal-title":"Br J Haematol"},{"issue":"11","key":"2026042809471524600_bib10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2017-10-811224","article-title":"Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma","volume":"131","author":"Herrera","year":"2018","journal-title":"Blood"},{"issue":"21","key":"2026042809471524600_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V116.21.766.766","article-title":"AHOD0031: a phase III study of dose-intensive therapy for intermediate risk Hodgkin lymphoma: a report from the Children's Oncology Group","volume":"116","author":"Friedman","year":"2010","journal-title":"Blood"},{"issue":"21","key":"2026042809471524600_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood.V116.21.767.767","article-title":"A phase III study for the treatment of children and adolescents with newly diagnosed low risk Hodgkin lymphoma (HL)","volume":"116","author":"Keller","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2026042809471524600_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.16014","article-title":"Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group","volume":"187","author":"Kelly","year":"2019","journal-title":"Br J Haematol"},{"issue":"7","key":"2026042809471524600_bib14","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1172\/JCI95993","article-title":"Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells","volume":"128","author":"Weniger","year":"2018","journal-title":"J Clin Invest"},{"issue":"22","key":"2026042809471524600_bib59","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2026042809471524600_bib60","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI200316624","article-title":"Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling","volume":"111","author":"K\u00fcppers","year":"2003","journal-title":"J Clin Invest"},{"issue":"10","key":"2026042809471524600_bib61","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","article-title":"Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis","volume":"205","author":"Brune","year":"2008","journal-title":"J Exp Med"},{"issue":"7","key":"2026042809471524600_bib62","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.exphem.2008.02.014","article-title":"Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs","volume":"36","author":"Staege","year":"2008","journal-title":"Exp Hematol"},{"issue":"6","key":"2026042809471524600_bib63","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.2012.43.4589","article-title":"Gene expression-based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma","volume":"31","author":"Scott","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"2026042809471524600_bib64","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"2026042809471524600_bib23","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1182\/blood-2012-05-428896","article-title":"Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma","volume":"120","author":"Tiacci","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2026042809471524600_bib65","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2005-12-5125","article-title":"Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma","volume":"108","author":"S\u00e1nchez-Aguilera","year":"2006","journal-title":"Blood"},{"issue":"8","key":"2026042809471524600_bib22","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1182\/blood-2010-02-270009","article-title":"A molecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma","volume":"116","author":"S\u00e1nchez-Espiridi\u00f3n","year":"2010","journal-title":"Blood"},{"issue":"19","key":"2026042809471524600_bib66","first-page":"2343","article-title":"Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma","volume":"141","author":"Stewart","year":"2023","journal-title":"Blood"},{"issue":"7","key":"2026042809471524600_bib67","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2026042809471524600_bib68","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","article-title":"Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells","volume":"4","author":"Maura","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"23","key":"2026042809471524600_bib69","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"2026042809471524600_bib70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/hon.2523","article-title":"Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma","volume":"36","author":"Vera-Lozada","year":"2018","journal-title":"Hematol Oncol"},{"issue":"23","key":"2026042809471524600_bib71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1182\/blood.V126.23.175.175","article-title":"Prediction of primary treatment outcome using gene expression profiling of pre-treatment biopsies obtained from childhood and adolescent Hodgkin lymphoma patients","volume":"126","author":"Mottok","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2026042809471524600_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","article-title":"Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma","volume":"34","author":"Desch","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"2026042809471524600_bib73","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1182\/blood.2021011941","article-title":"A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma","volume":"139","author":"Johnston","year":"2022","journal-title":"Blood"},{"issue":"5","key":"2026042809471524600_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"2026042809471524600_bib16","doi-asserted-by":"crossref","first-page":"387034","DOI":"10.1155\/2011\/387034","article-title":"Flow cytometric detection of the classical hodgkin lymphoma: clinical and research applications","volume":"2011","author":"Roshal","year":"2011","journal-title":"Adv Hematol"},{"issue":"1","key":"2026042809471524600_bib17","doi-asserted-by":"crossref","first-page":"2033433","DOI":"10.1080\/2162402X.2022.2033433","article-title":"CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: characterizing CD4+ T cells in Hodgkin lymphoma","volume":"11","author":"Veldman","year":"2022","journal-title":"Oncoimmunology"},{"key":"2026042809471524600_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"2026042809471524600_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"issue":"12","key":"2026042809471524600_bib20","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3390\/cancers12123603","article-title":"Defining the inflammatory plasma proteome in pediatric Hodgkin lymphoma","volume":"12","author":"Agrusa","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"19","key":"2026042809471524600_bib21","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene expression profiling defines molecular subtypes of classical Hodgkin's disease","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"issue":"7","key":"2026042809471524600_bib24","first-page":"1644","article-title":"Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma","volume":"63","author":"Br\u00e4uninger","year":"2003","journal-title":"Cancer Res"},{"issue":"9","key":"2026042809471524600_bib25","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","article-title":"Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"issue":"4","key":"2026042809471524600_bib26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"issue":"10","key":"2026042809471524600_bib27","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1172\/JCI61245","article-title":"Hodgkin lymphoma","volume":"122","author":"K\u00fcppers","year":"2012","journal-title":"J Clin Invest"},{"issue":"23","key":"2026042809471524600_bib28","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development","volume":"91","author":"K\u00fcppers","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2026042809471524600_bib29","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"issue":"4","key":"2026042809471524600_bib30","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","article-title":"Molecular biology of Hodgkin lymphoma","volume":"35","author":"Weniger","year":"2021","journal-title":"Leukemia"},{"issue":"12","key":"2026042809471524600_bib31","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.exphem.2013.09.014","article-title":"Immunologic pathomechanism of Hodgkin's lymphoma","volume":"41","author":"Jona","year":"2013","journal-title":"Exp Hematol"},{"issue":"4","key":"2026042809471524600_bib32","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2026042809471524600_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.20021279","article-title":"XIAP-mediated caspase inhibition in Hodgkin's lymphoma-derived B cells","volume":"198","author":"Kashkar","year":"2003","journal-title":"J Exp Med"},{"issue":"8","key":"2026042809471524600_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.20031080","article-title":"c-FLIP mediates resistance of Hodgkin\/Reed-Sternberg cells to death receptor-induced apoptosis","volume":"199","author":"Mathas","year":"2004","journal-title":"J Exp Med"},{"issue":"12","key":"2026042809471524600_bib35","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood-2004-12-4750","article-title":"From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential","volume":"105","author":"Re","year":"2005","journal-title":"Blood"},{"issue":"9","key":"2026042809471524600_bib36","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2026042809471524600_bib37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/leu.2011.265","article-title":"Notch is an essential upstream regulator of NF-\u03baB and is relevant for survival of Hodgkin and Reed-Sternberg cells","volume":"26","author":"Schwarzer","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"2026042809471524600_bib38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.1725","article-title":"Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR","volume":"205","author":"Dutton","year":"2005","journal-title":"J Pathol"},{"key":"2026042809471524600_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"2026042809471524600_bib40","doi-asserted-by":"crossref","first-page":"593630","DOI":"10.3389\/fphys.2020.593630","article-title":"Senescent cell depletion through targeting BCL-family proteins and mitochondria","volume":"11","author":"Fan","year":"2020","journal-title":"Front Physiol"},{"issue":"10","key":"2026042809471524600_bib41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/aps.2017.198","article-title":"Oncogene-induced senescence: a double edged sword in cancer","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"2026042809471524600_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2026042809471524600_bib43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"5","key":"2026042809471524600_bib44","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41591-021-01304-x","article-title":"BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology","volume":"27","author":"Bigenwald","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"2026042809471524600_bib45","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41375-019-0611-9","article-title":"Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma","volume":"34","author":"Adams","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"2026042809471524600_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/lrb.2007.5305","article-title":"Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma","volume":"5","author":"Akta\u015f","year":"2007","journal-title":"Lymphat Res Biol"},{"issue":"1","key":"2026042809471524600_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2006.06.017","article-title":"Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomas","volume":"38","author":"Bai","year":"2007","journal-title":"Hum Pathol"},{"issue":"2","key":"2026042809471524600_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF01715132","article-title":"The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood","volume":"68","author":"Claviez","year":"1994","journal-title":"Ann Hematol"},{"issue":"5","key":"2026042809471524600_bib49","first-page":"526","article-title":"Low apoptotic index & bak expression in EBV-associated childhood classical Hodgkin lymphoma","volume":"130","author":"Dinand","year":"2009","journal-title":"Indian J Med Res"},{"issue":"2","key":"2026042809471524600_bib50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00109-005-0003-7","article-title":"cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3","volume":"84","author":"D\u00fcrkop","year":"2006","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"2026042809471524600_bib51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2002-04-1128","article-title":"Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays","volume":"101","author":"Garc\u00eda","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2026042809471524600_bib52","doi-asserted-by":"crossref","first-page":"e2457","DOI":"10.1038\/cddis.2016.185","article-title":"Reed-Sternberg cells in Hodgkin's lymphoma present features of cellular senescence","volume":"7","author":"Gopas","year":"2016","journal-title":"Cell Death Dis"},{"issue":"7","key":"2026042809471524600_bib53","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/10428190902943069","article-title":"Targeting the Bcl-2 family of proteins in Hodgkin lymphoma: in vitro cytotoxicity, target modulation and drug combination studies of the Bcl-2 homology 3 mimetic ABT-737","volume":"50","author":"Jayanthan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"2026042809471524600_bib54","doi-asserted-by":"crossref","first-page":"118979","DOI":"10.1016\/j.lfs.2020.118979","article-title":"Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin lymphoma","volume":"268","author":"Gamboa-Cede\u00f1o","year":"2021","journal-title":"Life Sci"},{"issue":"7814","key":"2026042809471524600_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"key":"2026042809471524600_bib56","doi-asserted-by":"crossref","first-page":"109173","DOI":"10.1016\/j.biopha.2019.109173","article-title":"Basing on uPAR-binding fragment to design chimeric antigen receptors triggers antitumor efficacy against uPAR expressing ovarian cancer cells","volume":"117","author":"Wang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2026042809471524600_bib57","doi-asserted-by":"crossref","first-page":"153964","DOI":"10.1016\/j.prp.2022.153964","article-title":"Autophagy and cellular senescence in classical Hodgkin lymphoma","volume":"236","author":"Kyriazopoulou","year":"2022","journal-title":"Pathol Res Pract"},{"issue":"1","key":"2026042809471524600_bib58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12672-024-01161-3","article-title":"Combination of BCL-2 inhibitors and immunotherapy: a promising therapeutic strategy for hematological malignancies","volume":"15","author":"Peng","year":"2024","journal-title":"Discov Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2711\/2514254\/blooda_adv-2025-016953-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2711\/2514254\/blooda_adv-2025-016953-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:47:34Z","timestamp":1777384054000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/8\/2711\/566016\/Disordered-differentiation-and-cellular-senescence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016953","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,28]]},"published":{"date-parts":[[2026,4,17]]}}}